Understand the source comparison
Follistatin-344 Dosage Protocol Comparison
Standard Research Protocol 100mcg Daily (every 24 hours) 700mcg Baseline myostatin inhibition studies, minimal off-target effects Most reproducible results for long-term trials; lowest risk of activin pathway interference Moderate-Intensity Protocol 200mcg 140
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Standard Research Protocol
- 100mcg
- Daily (every 24 hours)
- 700mcg
- Baseline myostatin inhibition studies, minimal off-target effects
- Most reproducible results for long-term trials; lowest risk of activin pathway interference
- Moderate-Intensity Protocol
- 200mcg
- 1400mcg
- Accelerated muscle hypertrophy observation, dose-response studies
- Provides measurable gains over 100mcg daily without entering non-linear dose range
- Alternate-Day Protocol
- Every 48 hours
- Extended observation periods, minimising total peptide exposure
- Matches daily 100mcg for myostatin suppression with half the administration frequency
- High-Dose Research Protocol
- 300mcg
- 2100mcg
- Maximum myostatin inhibition, short-term hypertrophy studies
- Approaches non-linear dose-response threshold; limited additional benefit over 200mcg daily